T. A. Moreland
- Pediatrics, Perinatology and Child Health top 5%
- Psychiatry and Mental health top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Pharmacology top 10%
- Pharmacology top 5%
- Co-authors
- D S HewickRené H. LevyIan H. StevensonAlexander M. M. ShepherdG RylanceJohn McEwenChristian de MeyMartin C. Michel
- Topics
- Pharmacological Effects and Toxicity Studies (7 papers)Antibiotics Pharmacokinetics and Efficacy (7 papers)Pharmaceutical studies and practices (7 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
T. A. Moreland
35 papers receiving 860 citations
Peers
Comparison fields: 5 of 101
- Pediatrics, Perinatology and Child Health 313
- Psychiatry and Mental health 221
- Cardiology and Cardiovascular Medicine 168
- Pharmacology 150
- Pharmacology 141
Countries citing papers authored by T. A. Moreland
This map shows the geographic impact of T. A. Moreland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. A. Moreland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. A. Moreland more than expected).
Fields of papers citing papers by T. A. Moreland
This network shows the impact of papers produced by T. A. Moreland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. A. Moreland. The network helps show where T. A. Moreland may publish in the future.
Co-authorship network of co-authors of T. A. Moreland
This figure shows the co-authorship network connecting the top 25 collaborators of T. A. Moreland. A scholar is included among the top collaborators of T. A. Moreland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. A. Moreland. T. A. Moreland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 80 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 17 | |
| 6 | 5 | |
| 7 | Sustained-release verapamil: multiple-dose pharmacokinetic comparison of 120-mg and 240-mg tablets and the effect of halving a 240-mg tablet. | 8 |
| 8 | 34 | |
| 9 | 7 | |
| 10 | 39 | |
| 11 | 8 | |
| 12 | 6 | |
| 13 | 36 | |
| 14 | 1 | |
| 15 | 17 | |
| 16 | 25 | |
| 17 | 190 | |
| 18 | Proceedings: An NADPH dependent warfarin reductase in human and rat liver and kidney soluble fraction. | 1 |
| 19 | The effect of age on the sensitivity to warfarin sodium | 16 |
| 20 | 50 |
About T. A. Moreland
T. A. Moreland is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Analytical Chemistry, having authored 35 papers that have together received 943 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pharmaceutical studies and practices (7 papers). The work is most often cited by research in Pharmacology (141 citations), Pediatrics, Perinatology and Child Health (313 citations) and Psychiatry and Mental health (221 citations). T. A. Moreland has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include D S Hewick, René H. Levy, Ian H. Stevenson, Alexander M. M. Shepherd, G Rylance, John McEwen, Christian de Mey, Martin C. Michel, P Loiseau and Henri Bléhaut. Their work appears in journals such as Clinical Infectious Diseases, European Heart Journal and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.